Ratings by Needham (Joseph Stringer)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | Shattuck Labs | STTK | New Coverage | Buy (N/A) |
17.42 (5.99) |
-65.61% | Details | |
| 2/24/2026 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2026 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2025 | Vir Biotechnology | VIR | Maintain | Under Review (N/A) |
|
Details | ||
| 11/21/2025 | Moderna | MRNA | Maintain | Hold (Hold) |
|
Details | ||
| 11/14/2025 | Cidara Therapeutics | CDTX | Downgrade | Hold (Buy) |
105.99 (221.38) |
108.87% | Details | |
| 11/7/2025 | Cidara Therapeutics | CDTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2025 | Avidity Biosciences | RNA | Downgrade | Hold (Buy) |
49.15 (14.82) |
-69.85% | Details | |
| 10/20/2025 | Moderna | MRNA | Maintain | Hold (Hold) |
|
Details | ||
| 10/10/2025 | Stoke Therapeutics | STOK | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2025 | Gilead Sciences | GILD | Maintain | Buy (Buy) |
|
Details | ||
| 8/8/2025 | Cidara Therapeutics | CDTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2025 | Gilead Sciences | GILD | Upgrade | Buy (Hold) |
113.20 (143.93) |
27.15% | Details | |
| 6/26/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2025 | Cidara Therapeutics | CDTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2025 | Inozyme Pharma Inc. | INZY | Downgrade | Hold (Buy) |
1.42 (4.00) |
181.69% | Details | |
| 9/3/2024 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 6/13/2024 | Cara Therapeutics | CARA | Downgrade | Hold (Buy) |
0.68 (5.32) |
682.35% | Details | |
| 6/5/2024 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2024 | Cidara Therapeutics | CDTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2024 | Stoke Therapeutics | STOK | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2023 | Intercept Pharmaceuticals | ICPT | Downgrade | Hold (Buy) |
9.53 (19.00) |
99.37% | Details | |
| 5/5/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2023 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2023 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2023 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2022 | Theravance Biopharma | TBPH | Maintain | Hold (Hold) |
|
Details | ||
| 7/14/2022 | Zealand Pharma A/S | ZEAL | Maintain | Buy (Buy) |
|
Details | ||
| 7/13/2022 | Vaxcyte | PCVX | Maintain | Buy (Buy) |
|
Details | ||
| 7/8/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (Buy) |
|
Details | ||
| 7/8/2022 | Cidara Therapeutics | CDTX | Maintain | Buy (Buy) |
|
Details | ||
| 6/23/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (Buy) |
|
Details | ||
| 6/7/2022 | Annexon Biosciences | ANNX | Maintain | Buy (Buy) |
|
Details | ||
| 5/25/2022 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (Buy) |
|
Details | ||
| 5/19/2022 | Zealand Pharma A/S | ZEAL | Maintain | Buy (Buy) |
|
Details | ||
| 5/18/2022 | Moderna | MRNA | Maintain | Hold (Hold) |
|
Details | ||
| 5/6/2022 | Theravance Biopharma | TBPH | Maintain | Hold (Hold) |
|
Details | ||
| 5/6/2022 | Vir Biotechnology | VIR | Maintain | Buy (Buy) |
|
Details | ||
| 5/5/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (Buy) |
|
Details | ||
| 5/4/2022 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (Buy) |
|
Details | ||
| 4/8/2022 | Annexon Biosciences | ANNX | Maintain | Buy (Buy) |
|
Details | ||
| 4/8/2022 | Annexon Biosciences | ANNX | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2022 | Vaxcyte | PCVX | Maintain | Buy (Buy) |
|
Details | ||
| 4/4/2022 | Inozyme Pharma Inc. | INZY | Maintain | Buy (Buy) |
|
Details | ||
| 4/4/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (Buy) |
|
Details | ||
| 3/30/2022 | Zealand Pharma A/S | ZEAL | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2022 | Vir Biotechnology | VIR | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2022 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2022 | Inozyme Pharma Inc. | INZY | Maintain | Buy (Buy) |
|
Details | ||
| 3/16/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (Buy) |
|
Details | ||
| 3/14/2022 | Cara Therapeutics | CARA | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2022 | Zealand Pharma A/S | ZEAL | Maintain | Buy (Buy) |
|
Details | ||
| 3/8/2022 | Cidara Therapeutics | CDTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2022 | Annexon Biosciences | ANNX | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Cara Therapeutics | CARA | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Avidity Biosciences | RNA | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (Buy) |
|
Details | ||
| 12/31/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2021 | Arena Pharma | ARNA | Downgrade | Hold (Buy) |
49.94 (99.98) |
100.2% | Details | |
| 11/29/2021 | Inozyme Pharma Inc. | INZY | New Coverage | Buy (N/A) |
8.00 (4.00) |
-50% | Details | |
| 11/22/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2021 | Theravance Biopharma | TBPH | Downgrade | Hold (Buy) |
8.04 (13.57) |
68.78% | Details | |
| 9/10/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2021 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2021 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2021 | Gilead Sciences | GILD | Maintain | Hold (N/A) |
|
Details | ||
| 7/29/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2021 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2021 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2021 | Annexon Biosciences | ANNX | New Coverage | Buy (N/A) |
25.50 (5.16) |
-79.76% | Details | |
| 1/14/2021 | Stoke Therapeutics | STOK | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2020 | Stoke Therapeutics | STOK | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2020 | Stoke Therapeutics | STOK | New Coverage | Buy (N/A) |
34.93 (35.48) |
1.57% | Details |
